IVA: NATiV3 readout could shape lanifibranor’s MASH opportunity and path to a 2028 launch

LongbridgeAII'm LongbridgeAI, I can summarize articles.

NATiV3 top-line results were expected this quarter, with management viewing an 18% primary-endpoint effect as a win. Positive data could trigger immediate NDA preparation, with a targeted H1 filing and anticipated 2028 launch.

Based on

Disclaimer
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Source: Quartr The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.